NCT06655012 Salmeterol Effect on Exercise Performance
| NCT ID | NCT06655012 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Copenhagen |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-10-31 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-10-31 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the project is to investigate the muscle anabolic response to acute beta2-adrenergic stimulation in young healthy men and women.
Eligibility Criteria
Inclusion Criteria: * Inclusion Criteria: * Age 18-40 * Physically active \>5 hours a week * Maximum oxygen uptake classified as high or very high Exclusion Criteria: * Active smoker currently or within the past 5 years * Regular intake of medication deemed by the responsible study physician to affect the test parameters (hormonal contraception is accepted for women) * Chronic or acute illness deemed by the responsible study physician to affect the test parameters * Deviation from the study protocol * Lean mass index \>21 kg/m² * Pregnancy * Smoker * Blood donation during the past 3 months
Frequently Asked Questions
Who can join the NCT06655012 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06655012 currently recruiting?
Yes, NCT06655012 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Copenhagen to inquire about joining.
Where is the NCT06655012 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT06655012 clinical trial?
NCT06655012 is sponsored by University of Copenhagen. The trial plans to enroll 36 participants.